Nancy Boman
About Nancy Boman
Nancy Boman is a seasoned Chief Regulatory Officer with a background in medicine and biochemistry, boasting nearly 30 years of experience in the biotech and pharmaceutical industry.
Nancy Boman Chief Regulatory Officer
Nancy Boman serves as the Chief Regulatory Officer, a role that taps into her extensive experience in the biotech and pharmaceutical industries. With nearly 30 years in the field, Boman has established herself as an expert in regulatory strategy and operations, clinical development, and chemistry, manufacturing, and controls (CMC). Her leadership has been instrumental in advancing drug marketing applications across various indications, including hematologic malignancies and solid tumors.
Nancy Boman Education and Credentials
Nancy Boman holds an M.D. in Human Medicine and a Ph.D. in Biochemistry, underpinning her scientific expertise with a robust foundation in both practical and theoretical knowledge. She earned her B.Sc. in General Science from The University of British Columbia, which laid the groundwork for her distinguished career in the biotech and pharmaceutical sectors.
Nancy Boman Biotech and Pharmaceutical Industry Experience
Nancy Boman brings nearly three decades of experience to the biotech and pharmaceutical industries. Her tenure includes senior roles in regulatory affairs and clinical development at prominent organizations such as Alder BioPharmaceuticals, Cell Therapeutics, Genentech, and Amgen. These roles have provided her with a broad and deep understanding of the complexities involved in drug development and regulatory approval processes.
Nancy Boman Leadership in Drug Marketing Applications
Nancy Boman has led more than 15 drug marketing applications, showcasing her comprehensive expertise in the regulatory landscape. Her leadership extends to multiple therapeutic areas, notably in hematologic malignancies and solid tumors. Her strategic oversight has been pivotal in guiding these complex applications through regulatory channels successfully.
Nancy Boman Previous Roles at Encoded Therapeutics and AveXis Inc.
Before her current role, Nancy Boman served as the Chief Regulatory Officer at Encoded Therapeutics and AveXis Inc. (now Novartis Gene Therapies). At both companies, she was responsible for developing and implementing regulatory strategies that aligned with their business objectives, playing a crucial role in their advancement within the biotech sector.